Fight for an NHS that passes the Makerfield test – CLPD

Share

“Market-driven policies leave communities like Makerfield with the greatest health needs and on the wrong side of widening inequalities.”

The Campaign for Labour Party Democracy has released the following motion template for Labour members to submit to this year’s Labour Party Annual Conference.

Conference celebrates 78 years of Labour’s National Health Service.

Conference notes with concern NHS England’s 13 August 2026 press release, showing the waiting list rising back to 7.3 million, barely 4% below July 2024’s 7.6 million.

Moreover, 90,000–100,000 of the 110,000 March 2026 waiting-list drop were financially incentivised administrative “Unvalidated Removals”, not patients treated.

Conference further notes:

  • the Royal College of Emergency Medicine associates prolonged A&E waits with over 300 deaths weekly;
  • maternal mortality at its highest for almost two decades, disproportionately harming Black, Asian and poor communities;
  • research showing outsourcing causes excess preventable mortality, widens inequality, undermines NHS services and costs more than in- house provision;
  • Trusts crippled by PFI debt, while £16 billion of needed repairs endanger staff and patients.

Conference believes marketised health and care services fail our Prime Minister’s Makerfield test. Market-driven policies leave communities like Makerfield with the greatest health needs and on the wrong side of widening inequalities.

Conference resolves that Labour must:

  • Reinstate the NHS as a fully publicly owned, publicly provided, fully funded, fully resourced and free service, delivered on need — restoring the Secretary of State’s duty to provide, ending the purchaser– provider split and removing market mechanisms;
  • End outsourcing, suspend A&E and maternity closures pending equality impact assessments, restore workers’ pay against inflation and update Agenda for Change;
  • Reject PFI-style funding, prepare to exercise the Palantir break clause and terminate or renegotiate the US-UK pharmaceutical deal.

Photo credit: Rawpixel
Used under Creative Commons Licence

Leave a Reply